How much is Sidera Bio worth in 2026?

Sidera Bio has a current valuation of N/A based on their Early Stage VC round and secondary market data.

How much funding has Sidera Bio raised?

Sidera Bio has raised $109.0M in total funding across 1 funding rounds.

Sidera Bio

Drug DiscoveryWebsite

Sidera Bio valuation and funding history | Last updated: December 8, 2025 | 1 funding rounds

Current Valuation

N/A

As of December 8, 2025

Total Funding Raised

$109.0M

Across 1 round

Last Round

Early Stage VC

$109.0M

Last Funding

Dec 2025

Funding date

Capital Efficiency

N/A

Valuation / Funding

Funding History & Valuation Timeline

Complete history of all funding rounds and valuation milestones

Date	Round	Amount	Post-Valuation	Growth
December 8, 2025	Early Stage VC (Series A)	$109.0M	N/A	-

Valuation Analysis

Current Valuation Metrics

Sidera Bio is currently valued at N/A as of December 8, 2025. The company has raised a total of $109.0M in funding across 1 funding round.

Track Sidera Bio Valuation Updates

Get notified when Sidera Bio raises new funding or valuation changes

Explore More Data

Detailed analysis for Sidera Bio

Secondary Market Price

Real-time pricing data and trends

Valuation Tracker

Historical valuation changes

Funding History

Complete funding round timeline

Secondary Price History

Historical transaction data

All Investors

Complete list of all investors

View 5 companies free

Create a free account to unlock Sidera Bio's valuation history, funding rounds, and growth metrics.

No credit card required

What is Sidera Bio Worth in 2026?

Sidera Bio is a leading private company in the Drug Discovery sector. Track Sidera Bio's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.

How Sidera Bio Valuation is Determined

Private company valuations like Sidera Bio's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.